Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stig Lenhoff

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Haematologica|October 6, 2022
Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patientsKonstantinos Lemonakis, Love Tatting, Mikael Lisak, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study groupHans E Johnsen, Tobias W Klausen, Martin Boegsted, et al.
Scientific Reports|December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulinMikael Lisak, Malin Nicklasson, Robert Palmason, et al.
European Journal of Haematology|March 14, 2018
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort studyKrista Vaht, Magnus Göransson, Kristina Carlson, et al.
Haematologica|July 29, 2017
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011Krista Vaht, Magnus Göransson, Kristina Carlson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort StudyKrista Vaht, Magnus Göransson, Kristina Carlson, et al.
European Journal of Haematology|August 26, 2006
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cellsAnne K Mylin, Thomas Rasmussen, Julia S Johansen, et al.
British Journal of Haematology|April 3, 2004
Early response predicts thalidomide efficiency in patients with advanced multiple myelomaAnders Waage, Peter Gimsing, Gunnar Juliusson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastomaJacek Toporski, Michael Garkavij, Jan Tennvall, et al.
Bone Marrow Transplantation|April 10, 2019
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registryAnna Lübking, Arta Dreimane, Fredrik Sandin, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Haematologica|October 6, 2022
Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patientsKonstantinos Lemonakis, Love Tatting, Mikael Lisak, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study groupHans E Johnsen, Tobias W Klausen, Martin Boegsted, et al.
Scientific Reports|December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulinMikael Lisak, Malin Nicklasson, Robert Palmason, et al.
European Journal of Haematology|March 14, 2018
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort studyKrista Vaht, Magnus Göransson, Kristina Carlson, et al.
Haematologica|July 29, 2017
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011Krista Vaht, Magnus Göransson, Kristina Carlson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort StudyKrista Vaht, Magnus Göransson, Kristina Carlson, et al.
European Journal of Haematology|August 26, 2006
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cellsAnne K Mylin, Thomas Rasmussen, Julia S Johansen, et al.
British Journal of Haematology|April 3, 2004
Early response predicts thalidomide efficiency in patients with advanced multiple myelomaAnders Waage, Peter Gimsing, Gunnar Juliusson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastomaJacek Toporski, Michael Garkavij, Jan Tennvall, et al.
Bone Marrow Transplantation|April 10, 2019
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registryAnna Lübking, Arta Dreimane, Fredrik Sandin, et al.
Pageof 8